St. Clair Advisors, LLC

Position in GILD — Gilead Sciences, Inc.

CIK 2056292 MAYFIELD HTS, OH

Position in GILD

as of Jun 30, 2026 · filed Jul 6, 2026 Compact

Position Value

$659,368

-$68,004 QoQ

Shares Held

5,219

0.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.47%

of 13F equity value

Holder Rank

#1,254

of 2,266 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

St. Clair Advisors, LLC holds $10,019,901 across 6 Drug Manufacturers - General names. GILD ranks #6 (6.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	21,699	$5,510,895
2	NVS	Novartis AG	7,092	$1,111,458
3	AMGN	Amgen Inc	2,725	$986,777
4	PFE	Pfizer Inc	39,391	$948,535
5	MRK	Merck & Co., Inc.	6,248	$802,868
6	GILD	Gilead Sciences, Inc. This page	5,219	$659,368

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$659,368	5,219	0.0%	Shares	Sole	2026-07-06
2026-03-31	$727,372	5,219	0.0%	Shares	Sole	2026-04-23
2025-12-31	$640,580	5,219	0.0%	Shares	Sole	2026-01-20
2025-09-30	$579,309	5,219	0.0%	Shares	Sole	2025-10-03
2025-06-30	$578,630	5,219	0.0%	Shares	Sole	2025-07-07
2025-03-31	$584,788	5,219	0.0%	Shares	Sole	2025-04-24
2024-12-31	$482,079	5,219	0.0%	Shares	Sole	2025-02-14
2024-09-30	$437,560	5,219	0.0%	Shares	Sole	2025-04-10
2024-06-30	$358,075	5,219	0.0%	Shares	Sole	2025-04-10
2024-03-31	$382,291	5,219	0.0%	Shares	Sole	2025-04-10
2023-12-31	$422,791	5,219	-16.1%	Shares	Sole	2025-04-10
2023-09-30	$466,051	6,219	0.0%	Shares	Sole	2025-04-10
2023-06-30	$479,298	6,219	+16.0%	Shares	Sole	2025-04-10
2023-03-31	$444,719	5,360	+127.1%	Shares	Sole	2025-04-10
2022-12-31	$202,606	2,360	—	Shares	Sole	2025-04-10
No filing history on record for this holder in this stock.